EKF

EKF Life Sciences and ABEC Partner for US Biomanufacturing Expansion

Retrieved on: 
Dienstag, März 8, 2022
Engineering, Health, Medical Devices, Manufacturing, Other Manufacturing, Pharmaceutical, Biotechnology, Industry, EKF, Enzyme, Solution, Fermentation, IVD, Life, Multimedia, CEO, Technology transfer, Engineering, Partnership, List of life sciences, Fine chemical, Management, ABEC, ABEC, EKF LIFE SCIENCES

The agreement provides EKF Life Sciences South Bend, Indiana facility with the bioprocess equipment which will significantly expand EKFs production capacity of enzymes used in a variety of diagnostic and Life Science applications.

Key Points: 
  • The agreement provides EKF Life Sciences South Bend, Indiana facility with the bioprocess equipment which will significantly expand EKFs production capacity of enzymes used in a variety of diagnostic and Life Science applications.
  • ABEC has over 45 years of experience in large-scale fermenter design and complete in-house engineering and manufacturing capabilities.
  • EKF Life Sciences is dedicated to developing new products and capabilities that best serve the in vitro diagnostic market on a global scale.
  • EKF Life Sciences has been manufacturing enzymes and related biomolecules from bacterial fermentation for use in IVD since 1983.

RedHill Biopharma to Present at H.C. Wainwright 7th Annual Israel Conference and German Equity Forum (EKF) 2021

Retrieved on: 
Dienstag, November 9, 2021
Genta (company), Cancer, Opioid, Private Securities Litigation Reform Act, Prostate cancer, Security (finance), EST, Gastritis, Risk, EKF, Cholangiocarcinoma, COVID-19, ABC294640, Diarrhea, Research, Forward-looking statement, Annual report, Crohn's disease, IBS-D, Xi, Vii, NTM, Authorization, Conference, Company, Ix, U.S. Securities and Exchange Commission, CET, SEC, Marketing, Nasdaq, Feedback, Patient, Redhill, Helicobacter pylori, Gastroenteritis, Pharmaceutical industry

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 9, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that Mr.

Key Points: 
  • TEL-AVIV, Israel and RALEIGH, N.C., Nov. 9, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that Mr.
  • RedHill promotes the gastrointestinal drugs, Movantik for opioid-induced constipation in adults[1], Taliciafor the treatment of Helicobacter pylori (H. pylori) infection in adults[2], and Aemcolo for the treatment of travelers' diarrhea in adults[3].
  • This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.
  • All forward-looking statements included in this press release are made only as of the date of this press release.

enCourage Kids Foundation Honoring Healthcare Heroes

Retrieved on: 
Donnerstag, März 11, 2021
EKF, Psychological resilience, Articles, Human behavior

Through its Honoring Healthcare Heroes Campaign, EKF will be highlighting stories of individuals in the healthcare industry who faced the past year and every day with courage and resilience and who make an immeasurable impact on the lives of their patients and families.

Key Points: 
  • Through its Honoring Healthcare Heroes Campaign, EKF will be highlighting stories of individuals in the healthcare industry who faced the past year and every day with courage and resilience and who make an immeasurable impact on the lives of their patients and families.
  • https://www.ekf-heroes.org
    "I'm so proud of the healthcare workers who risk their lives each and every day, especially during the pandemic," said Michele Hall Duncan, President and CEO, EKF.
  • "They're our true heroes and I'm grateful to work closely and assist them with their needs for hospitalized children that they care for."
  • https://krostnewyork.com
    Since 1985, EKF has helped humanize healthcare for children and their families by resourcing impact-driven pediatric programs and supporting the Child Life Community.

$3.77 Billion Simultaneous Localization and Mapping Technology Market - Global Industry Analysis and Growth Forecast to 2030

Retrieved on: 
Mittwoch, November 25, 2020
Robot control, Artificial intelligence, Simultaneous localization and mapping, EKF, Kalman filter, Slam, Computer science, Telecommunications engineering, EKF SLAM, GraphSLAM

DUBLIN, Nov. 25, 2020 /PRNewswire/ -- The "Simultaneous Localization and Mapping Technology Market Research Report: By Offering, Type, Application, End User - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 25, 2020 /PRNewswire/ -- The "Simultaneous Localization and Mapping Technology Market Research Report: By Offering, Type, Application, End User - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global simultaneous localization and mapping (SLAM) technology market is predicted to progress at a CAGR of 38.3% from 2020 to 2030 and attain a valuation of $3,775.3 million by 2030.
  • On the basis of type, the SLAM technology market is categorized into graph-based, fast, extended Kalman Filter (EKF), and others.
  • The AR/VR category under the application segmentation of the SLAM technology market is expected to register the highest CAGR in the market during 2020 - 2030.

Global Simultaneous Localization and Mapping Technology Market Research Report 2020-2030 - ResearchAndMarkets.com

Retrieved on: 
Mittwoch, November 18, 2020
Software, Technology, Satellite, Robot control, Artificial intelligence, Simultaneous localization and mapping, EKF, Slam, Kalman filter, Computer science, Telecommunications engineering, EKF SLAM, GraphSLAM

The "Simultaneous Localization and Mapping Technology Market Research Report: By Offering, Type, Application, End User - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Simultaneous Localization and Mapping Technology Market Research Report: By Offering, Type, Application, End User - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global simultaneous localization and mapping (SLAM) technology market is predicted to progress at a CAGR of 38.3% from 2020 to 2030 and attain a valuation of $3,775.3 million by 2030.
  • On the basis of type, the SLAM technology market is categorized into graph-based, fast, extended Kalman Filter (EKF), and others.
  • The AR/VR category under the application segmentation of the SLAM technology market is expected to register the highest CAGR in the market during 2020 - 2030.

17th Annual enCourage Kids Night at Citi Field Making a Difference for Children and Their Families

Retrieved on: 
Dienstag, Juni 4, 2019
Major League Baseball, Citi Field, Flushing Meadows–Corona Park, Jackie Robinson, EKF, New York Mets, Sports in the United States

NEW YORK, June 4, 2019 /PRNewswire/ --The enCourageKids Foundation (EKF) will host its 17th Annual Night at Citi Field on Thursday, June 13, 2019.

Key Points: 
  • NEW YORK, June 4, 2019 /PRNewswire/ --The enCourageKids Foundation (EKF) will host its 17th Annual Night at Citi Field on Thursday, June 13, 2019.
  • Join Michele Hall Duncan, President & CEO along with 850 enCourage Kids supporters and families for a great night of fun, food and baseball as the NY Mets take on the St. Louis Cardinals.
  • EKF helps humanize healthcare for children and their families by resourcing impact-driven pediatric programs and supporting the Child Life Community.
  • Michele has been featured in Social Lifestyle Magazine, Times Square Chronicles, Resident Magazine, ABC7, CBS New York and Spectrum1, to name a few.